Everything on Biotech

The acquisition of a one-person biotech company demonstrates that AI can significantly compress the timeline for drug discovery. This has implications for the cost and speed of bringing new treatments to market.

Impact: This could lead to a surge in AI-driven biotech startups, as the barriers to entry for drug development are lowered.

— from AI World Models and Biotech Disruption · The AI Daily Brief (Formerly The AI Breakdown): Artificial Intelligence News and Analysis· Oct 28, 2026

Eli Lilly is diversifying its revenue base by acquiring Merida Biosciences to reduce reliance on weight-loss drugs. The acquisition targets autoimmune and allergy treatments, securing long-term pipeline independence.

Impact: Mitigates regulatory and market saturation risks associated with single-product dependence, stabilizing long-term earnings projections.

— from Self-Storage Resilience and M&A Trends · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Sep 01, 2026